Top compounds associated with response to NRROS


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.34 4e-13
mRNA PD318088 CTRPv2 pan-cancer AAC 0.3 4e-11
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.28 7e-10
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.26 7e-09
mRNA ML239 CTRPv2 pan-cancer AAC 0.25 6e-08
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.24 7e-08
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 8e-08
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC 0.24 1e-07
mRNA YM-155 CTRPv2 pan-cancer AAC -0.26 1e-07
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.24 2e-07
Download CSV